Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
3.24
0.02 (0.62%)
At close: Aug 15, 2025, 3:06 PM

Theratechnologies Income Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Revenue
17.73M 19.05M 25M 22.6M 22.02M 16.25M 23.45M 20.86M 17.55M 19.91M 21.42M 20.81M 19.27M 18.56M 18.75M 17.85M 17.79M 15.43M
Cost of Revenue
4.7M 3.48M 6.1M 4.52M 4.55M 5.28M 5.07M 4.97M 4.91M 4.69M 5.91M 5.29M 8.98M 6.1M 6.41M 5.5M 5.93M 5.41M
Gross Profit
13.03M 15.56M 18.91M 18.08M 17.47M 10.96M 18.39M 15.89M 12.64M 15.21M 15.51M 15.52M 10.29M 12.46M 12.34M 12.35M 11.85M 10.02M
Operating Income
-1.9M 1.9M 919K 6.21M 3.29M -2.25M 2.67M 54K -7.94M -5.41M -5.71M -5.52M -20.96M -7.72M -8.06M -7.24M -5.35M -4.58M
Interest Income
57K 9K 355K 364K 342K 420K 168.08K 166K 209K 227K 145K 71K 54K 46K 52K 64K 54K 25K
Pretax Income
-4.22M 424K -6.88M 3.85M 1.1M -4.37M -2.68M -620K -9.89M -10.35M -7.79M -7.4M -22.61M -9.01M -9.88M -9.49M -6.37M -5.92M
Net Income
-4.46M 117K -7.9M 3.09M 987K -4.48M -2.75M -746K -10.01M -10.44M -7.93M -7.55M -22.73M -9.03M -9.9M -9.51M -6.39M -5.92M
Selling & General & Admin
12.32M 10.7M 12.1M 9.25M 9.46M 9.46M 10.49M 10.44M 10.2M 11.27M 11.77M 12.61M 20.19M 12.18M 11.73M 11.29M 10.79M 9.72M
Research & Development
2.61M 2.97M 5.88M 2.61M 4.72M 3.75M 5.23M 5.4M 10.39M 9.36M 9.46M 8.43M 11.06M 8M 8.68M 8.3M 6.42M 4.88M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
14.93M 13.67M 17.99M 11.87M 14.18M 13.21M 15.72M 15.83M 20.58M 20.62M 21.22M 21.04M 31.25M 20.18M 20.41M 19.59M 17.2M 14.6M
Interest Expense
1.11M 1.13M 2.42M 2.66M 2.69M 2.65M 2.85M 2.74M 2.48M 2.32M 2.26M 1.56M 1.38M 1.32M 1.38M 1.46M 1.44M 1.38M
Selling & Marketing Expenses
6.84M 6.47M 7.04M 6.31M 6.37M 5.7M 6.75M 6.73M 6.48M 6.81M 7.81M 8.4M 15.37M 7.81M 8.19M 7.66M 6.9M 6.16M
Cost & Expenses
19.63M 17.15M 24.08M 16.39M 18.73M 18.49M 20.78M 20.8M 25.49M 25.32M 27.13M 26.33M 40.23M 26.28M 26.82M 25.09M 23.14M 20.01M
Income Tax Expense
246K 307K 1.02M 756K 118K 110K 73K 126K 126K 96K 143K 151K 122K 27K 19K 18K 20K 6K
Shares Outstanding (Basic)
49.36M 49.36M 51.52M 51.52M 49.36M 49.36M 73.08M 73.08M 96.81M 96.81M 95.13M 95.13M 95.12M 95.12M 95.12M 94.95M 94.5M 84.69M
Shares Outstanding (Diluted)
49.36M 50.4M 49.37M 49.37M 49.37M 49.36M 73.08M 73.08M 96.81M 96.81M 95.13M 95.13M 95.12M 95.12M 95.12M 94.95M 94.5M 84.69M
EPS (Basic)
-0.09 0.00 -0.15 0.06 0.02 -0.09 -0.04 -0.01 -0.1 -0.11 -0.08 -0.08 -0.24 -0.1 -0.1 -0.1 -0.07 -0.07
EPS (Diluted)
-0.09 0.00 -0.16 0.06 0.02 -0.09 -0.04 -0.01 -0.1 -0.11 -0.08 -0.08 -0.24 -0.1 -0.1 -0.1 -0.07 -0.07
EBITDA
-2.64M 2.04M -3.97M 6.62M 4.47M -1.21M 711K 839K -6.47M -7.09M -4.59M -4.98M -12.74M -5.5M -6.31M -5.84M -2.75M -2.35M
EBIT
-3.11M 1.55M -4.47M 6.21M 3.29M -1.72M 135K 54K -7.4M -8.03M -5.53M -5.84M -21.23M -7.69M -8.5M -8.03M -4.93M -4.53M
Depreciation & Amortization
473K 491K 493K 405K 1.18M 517K 576K 785K 932K 939K 940K 856K 8.49M 2.18M 2.19M 2.19M 2.19M 2.19M